S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
NASDAQ:GRCL

Gracell Biotechnologies (GRCL) Earnings Date, Estimates & Call Transcripts

$4.00
+0.07 (+1.78%)
(As of 06/9/2023 ET)
Compare
Today's Range
$3.70
▼
$4.08
50-Day Range
$1.45
▼
$4.00
52-Week Range
$1.40
▼
$5.69
Volume
366,778 shs
Average Volume
214,960 shs
Market Capitalization
$270.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.33
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 21Estimated
Actual EPS
(May. 15)
-$0.35
Consensus EPS
(May. 15)
-$0.35
Last Year's Q2 EPS
(5/16/2022)
-$0.37
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

GRCL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GRCL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Gracell Biotechnologies Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.45)($0.11)($0.29)
Q2 20233($0.41)($0.12)($0.29)
Q3 20233($0.47)($0.12)($0.33)
Q4 20233($0.50)($0.13)($0.34)
FY 202312($1.83)($0.48)($1.26)

GRCL Earnings Date and Information

Gracell Biotechnologies last issued its quarterly earnings results on May 15th, 2023. The reported ($0.35) earnings per share for the quarter, hitting the consensus estimate of ($0.35). Gracell Biotechnologies has generated ($1.33) earnings per share over the last year (($1.33) diluted earnings per share). Earnings for Gracell Biotechnologies are expected to decrease in the coming year, from ($1.53) to ($1.65) per share. Gracell Biotechnologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off prior year's report dates.

Gracell Biotechnologies Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/21/2023
(Estimated)		        
5/15/2023Q1 2023($0.35)($0.35)($0.35)
3/13/2023Q4 2022($0.43)($0.30)+$0.13($0.30)    
11/14/2022Q3 2022($0.09)($0.36)($0.27)($0.36)    
8/15/2022Q2 2022($0.08)($0.32)($0.24)($0.32)    
5/16/2022Q1 2022($0.08)($0.37)($0.29)($0.37)    
3/14/2022Q4 2021($0.38)($0.30)+$0.08($0.30)    
11/14/2021Q3($0.12)($0.30)($0.18)($0.06)$0.06 million
8/16/20216/30/2021($0.12)($0.20)($0.08)($0.22)    
5/16/2021Q1($0.2130)($0.25)($0.0370)($0.25)
3/8/2021Q4($0.27)($0.16)+$0.11  












Gracell Biotechnologies Earnings - Frequently Asked Questions

When is Gracell Biotechnologies's earnings date?

Gracell Biotechnologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off last year's report dates. Learn more on GRCL's earnings history.

Did Gracell Biotechnologies beat their earnings estimates last quarter?

In the previous quarter, Gracell Biotechnologies (NASDAQ:GRCL) reported ($0.35) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.35). Learn more on analysts' earnings estimate vs. GRCL's actual earnings.

How much revenue does Gracell Biotechnologies generate each year?

Gracell Biotechnologies (NASDAQ:GRCL) has a recorded annual revenue of $60,000.00.

How much profit does Gracell Biotechnologies generate each year?

Gracell Biotechnologies (NASDAQ:GRCL) has a recorded net income of -$88.08 million. GRCL has generated -$1.33 earnings per share over the last four quarters.

What is Gracell Biotechnologies's EPS forecast for next year?

Gracell Biotechnologies's earnings are expected to decrease from ($1.53) per share to ($1.65) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:GRCL) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -